| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
21,106 |
17,978 |
$1.51M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
3,790 |
3,640 |
$408K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
3,504 |
3,259 |
$365K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,668 |
2,551 |
$279K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,379 |
1,327 |
$153K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
8,914 |
8,489 |
$108K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
6,083 |
5,761 |
$67K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,011 |
942 |
$61K |
| 99381 |
|
561 |
525 |
$54K |
| 87428 |
|
949 |
916 |
$43K |
| 92587 |
|
3,921 |
3,666 |
$42K |
| 99383 |
|
298 |
276 |
$33K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,341 |
1,241 |
$33K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,736 |
2,550 |
$23K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
3,107 |
2,985 |
$16K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
130 |
127 |
$14K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,829 |
1,235 |
$13K |
| 99382 |
|
114 |
104 |
$11K |
| 87807 |
|
1,267 |
1,124 |
$10K |
| 99384 |
|
63 |
57 |
$8K |
| 90710 |
|
817 |
759 |
$3K |
| 0001A |
|
107 |
103 |
$2K |
| 90674 |
|
33 |
33 |
$1K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
17 |
12 |
$1K |
| 90633 |
|
984 |
922 |
$1K |
| 99072 |
|
1,732 |
1,490 |
$956.63 |
| 0002A |
|
30 |
29 |
$720.00 |
| 99499 |
|
822 |
799 |
$631.81 |
| 90648 |
|
1,124 |
1,024 |
$555.94 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
19 |
19 |
$484.75 |
| 90670 |
|
1,483 |
1,366 |
$472.05 |
| 96127 |
|
222 |
201 |
$355.11 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
14 |
14 |
$296.06 |
| 90677 |
|
249 |
218 |
$282.89 |
| 99173 |
|
4,112 |
3,840 |
$141.81 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
26 |
24 |
$124.47 |
| 90700 |
|
789 |
737 |
$96.09 |
| 90680 |
|
1,084 |
987 |
$94.10 |
| 90651 |
|
409 |
380 |
$47.37 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
18 |
17 |
$44.33 |
| 90713 |
|
167 |
159 |
$36.89 |
| 91300 |
|
108 |
91 |
$0.70 |
| 90723 |
|
493 |
442 |
$0.00 |
| 90698 |
|
204 |
179 |
$0.00 |
| H0049 |
Alcohol and/or drug screening |
303 |
284 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
287 |
266 |
$0.00 |
| 90620 |
|
287 |
263 |
$0.00 |
| 90716 |
|
16 |
12 |
$0.00 |
| 90656 |
|
53 |
51 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
12 |
12 |
$0.00 |
| 36410 |
|
40 |
39 |
$0.00 |
| 90734 |
|
300 |
270 |
$0.00 |
| 90715 |
|
140 |
125 |
$0.00 |
| 96160 |
|
388 |
352 |
$0.00 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
14 |
14 |
$0.00 |